NCT00083577View on ClinicalTrials.gov

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 1998

Study Completion Date

May 31, 2005

Conditions
Multiple Myeloma
Interventions
DRUG

Thalidomide

Trial Locations (1)

72205

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00083577 - Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma | Biotech Hunter | Biotech Hunter